/Companies

AngioGenex

New York, US · Nevada corporation

Find your way into AngioGenex

Sign up to see every warm intro you have to AngioGenex

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AngioGenex team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

MM
Martin MurrayNamed on SEC filing
MA
Michael AronsteinNamed on SEC filing
MS
Michael StrageNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$260K disclosed across 1 round · 2021

▶$260KraisedDec 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin MurrayExecutive Officer, Director
  • Michael AronsteinExecutive Officer, Director
  • Michael StrageExecutive Officer, Director
Offering amount
$260K
Amount sold
$260K
First sale
Dec 2021
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has AngioGenex raised?
AngioGenex has disclosed $260K raised across 1 round.
Where is AngioGenex headquartered?
AngioGenex is headquartered in New York, US.